Independent sites without the time, staff or accounting experience to keep a close eye on sponsor billing and payments can avoid losing thousands of dollars by instituting a few best practices to help keep the cash flowing. Read More
COVID-19 should come as a prompt to the clinical research sector to rapidly reinvent itself as it works to design and launch clinical trials for vaccine and therapeutic candidates “in the teeth of the epidemic,” says Janet Woodcock, director of FDA’s Center for Drug Evaluation and Research. Read More
Designers of precision medicine trials need access to more data sources than traditional trials to refine the parameters of their studies and boost enrollment. Read More
The industry has been abuzz about risk-based monitoring (RBM) for much of the last decade, with the FDA indicating that it would like to see more sponsors give it a try. Read More
The research is clear: certified principal investigators (CPIs) and clinical research coordinators (CRCs) do better work compared with their peers who hold no certification. Much better work, in fact. Read More
Due to the vast influx of technology and the advent of Risk-Based Monitoring, the clinical research landscape is now evolving fast, and along with it, so are jobs in the field. Read More
eConsent has developed a reputation for being the next big technological innovation in clinical trials, and adoption efforts are accelerating. Read More
The media buzz last week on reported layoffs at IBM Watson Health ranged from calling it a “bloodbath” to something more surgical. Eventually, IBM Watson Health confirmed the layoffs at some of its acquired businesses, but wouldn’t say how many, and said it was continuing to hire in other new areas. Read More
Despite endless talk over the last decade of ways to make clinical trials shorter and simpler, trials have only gotten longer and more complicated. Read More
The Clinical Trials Transformation Initiative (CTTI)—the first consortium to pull widespread stakeholders together, including the FDA, to hash through and try to fix large-scale problems that have plagued the clinical research space—has turned 10. What has it accomplished? Read More
